Advertisement for orthosearch.org.uk
Results 1 - 1 of 1
Results per page:
The Journal of Bone & Joint Surgery British Volume
Vol. 86-B, Issue 4 | Pages 607 - 612
1 May 2004
Asano N Yamakazi T Seto M Matsumine A Yoshikawa H Uchida A

We investigated the rates of expression of bone morphogenetic protein-2 (BMP-2) in 29 adult patients with high-grade malignant fibrous histiocytoma of soft tissue, using the BMP-2-specific monoclonal antibody, AbH3b2/17, and found that they ranged from 1.9% to 78.9%. The survival at five years of the groups expressing high (≥30%) and low (< 30%) levels of BMP-2 was 85.7% and 36.3%, respectively. Multivariable analysis showed that only BMP-2 had prognostic significance for continuous disease-free survival and for overall survival (p < 0.05). Our findings indicate that over-expression of BMP-2 in malignant fibrous histiocytoma of soft tissue is the most reliable prognostic indicator of the parameters assessed.